Purple Biotech (PPBT) Shares Issued (2017 - 2025)
Purple Biotech (PPBT) reported Shares Issued of $1.3 million for Q4 2025, down 69.2% year-over-year from $4.4 million in Q4 2024, and down 39.71% quarter-over-quarter from $2.2 million in Q3 2025.
Purple Biotech (PPBT) Shares Issued (2017 - 2025) Analysis & Trends
Purple Biotech (PPBT) has 7 years of Shares Issued data on file, last reported at $1.3 million in Q4 2025.
- Shares Issued for Q4 2025 came in at $1.3 million, down 69.2% year-over-year; the trailing twelve-month figure through Dec 2025 was $4.2 million (down 27.01% YoY), and the FY2025 annual result was $4.2 million, down 27.01% from the prior year.
- Shares Issued slipped to $1.3 million in Q4 2025 per PPBT's latest filing, from $2.2 million in the prior quarter.
- Over five years, Shares Issued peaked at $4.4 million in Q4 2024 and troughed at -$636000.0 in Q4 2021.
- A 5-year average of $759666.7 and a median of $464500.0 in 2023 frame the typical range for Shares Issued.
- The sharpest annual moves came in 2021 and 2024: Shares Issued tumbled 111.3% in 2021, then soared 109075.0% in 2024.
- A 5-year view of Shares Issued shows it stood at -$636000.0 in 2021, then surged by 129.25% to $186000.0 in 2022, then plunged by 97.85% to $4000.0 in 2023, then soared by 109075.0% to $4.4 million in 2024, then plunged by 69.2% to $1.3 million in 2025.
- Business Quant data shows PPBT's Shares Issued at $1.3 million in Q4 2025, $2.2 million in Q3 2025, and $443000.0 in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | 5.40 Mn |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | - |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | 27.00 Mn |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | 26,927.15 |
| 10 | Purple Biotech | 242.86 Mn | 236.43 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.35 Mn |
| Dec 31, 2025 | 1.35 Mn |
| Sep 30, 2025 | 2.23 Mn |
| Sep 30, 2025 | 2.23 Mn |
| Jun 30, 2025 | 443,000.00 |
| Jun 30, 2025 | 443,000.00 |
| Mar 31, 2025 | 221,000.00 |
| Mar 31, 2025 | 221,000.00 |
| Dec 31, 2024 | 4.37 Mn |
| Dec 31, 2024 | 4.37 Mn |
| Sep 30, 2024 | 504,000.00 |
| Sep 30, 2024 | 504,000.00 |
| Jun 30, 2024 | 564,000.00 |
| Jun 30, 2024 | 564,000.00 |
| Mar 31, 2024 | 374,000.00 |
| Mar 31, 2024 | 374,000.00 |
| Dec 31, 2023 | 4,000.00 |
| Dec 31, 2023 | 4,000.00 |
| Sep 30, 2023 | 678,000.00 |
| Sep 30, 2023 | 678,000.00 |